Podcasts about Chief executive officer

In this episode of Ditch the Suits, we are going to dive deep into the evolving story of the American middle class, exploring why it's shrinking, why that matters, and what you can actually do about it. You'll hear both sides of the debate: the familiar narrative that the middle class is disappearing as the rich get richer, and a counter-narrative that challenges those assumptions with fresh data and perspective. We'll break down arguments and examine whether the “shrinking middle class” is really a crisis or simply a sign of changing times. By the end, you'll have a clearer understanding of what's really happening, why it impacts you, and how you can take control of your financial future.

Are you worried about how easy it is for your tween, teen, or college-age child to get alcohol, weed, vapes, or “wellness” gummies—and not sure where to even start the conversation? In this episode of Power Your Parenting: Moms of Teens, Colleen talks with Pam Jenkins, Chief Executive Officer of Shatterproof, a national nonprofit dedicated to reversing the addiction crisis in the United States. Pam explains how today's substances (like Delta-8, synthetic THC products, and vaping) are more accessible and more potent, why mental health and substance use are so tightly linked, and why clear parental expectations are one of the strongest protective factors. You'll hear practical, hopeful ways to start ongoing conversations, monitor wisely (without turning into the “drug police”), and support your child's mental health so they're less vulnerable to addiction. About Pam Jenkins Pam Jenkins is the Chief Executive Officer of Shatterproof, the leading national nonprofit focused on preventing and treating addiction and supporting long-term recovery. With a lifelong career in public health and health communication, Pam has led large-scale initiatives in areas such as cancer, cardiovascular disease, and substance use. She has worked on government campaigns about marijuana, youth alcohol use, and created widely recognized public-health symbols like the red dress for women's heart disease. Today, Pam leads Shatterproof's policy advocacy, prevention programs, and family resources, all aimed at transforming how America understands and addresses addiction. 3 Key Takeaways for Moms Access and potency have changed—your expectations still matter. Teens can easily access highly potent substances (like Delta-8 and other synthetic THC products, vapes, and stronger marijuana) in gas stations, convenience stores, and online. Even so, clear parental disapproval is one of the strongest protections against teen use. Don't assume your kids “just know” how you feel—say it plainly and repeat it often. Mental health and substance use are inseparable. Anxiety, depression, ADHD, trauma, and social isolation all increase a teen's vulnerability to drugs and alcohol—and drug use can, in turn, worsen or even trigger serious mental health issues like crippling anxiety, depression, and psychosis. Monitoring your child's mood, behavior, friendships, grades, and social connectedness is as important as watching for the substances themselves. Monitor early, talk often, and stay curious—not panicked. Effective prevention starts young: secure medications at home, know your child's friends, stay engaged with school, and watch for changes in behavior or peer groups. Have many short, specific conversations—especially before parties or transitions—using curiosity (“What usually happens at those parties?”) rather than accusations. You don't have to be an expert; you just need to be present, clear about your values, and willing to keep the dialogue going well into their college years. Find out more at: https://shatterproof.org/ Follow at: https://www.instagram.com/weareshatterproof/ Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of The Gate 15 Interview, Andy Jabbour speaks with Cody Barrrow, CEO, EclecticlQ. Cody is a cybersecurity industry leader with over 20 years of public and private sector experience in the US and EU, holding leadership positions within the Pentagon, National Security Agency/US Cyber Command, Fortune 25, and commercial vendors as well as a number of other positions with the US Government and across the cybersecurity community. Since 2019, he has been with EclecticIQ, the Amsterdam-based European leader in cybersecurity technologies servicing central governments and large enterprises, where he took over as Chief Executive Officer in 2024. Cody has a Bachelor of Science in Political Science from the University of Maryland. Learn more about Cody on LinkedIn.In the discussion Cody and Andy cover:Cody's background.EclecticIQ, “The Threat Intelligence Platform that understands your business”“I'm not really big on hype.” Cody's perspective on threats, resilience, AI and more.Single points-of-failure, reducing dependencies, and “being anti-fragile”The importance of being adaptableCoffee and whisky, all day longBeing an ex-patRanch dressingAnd more!Selected links:⁠EclecticIQ⁠

This week Nicola and Di chat with the entertaining and genuine Ben Fordham. Ben is one of Australia’s most well-known media personalities, hosting the incredibly popular Breakfast Show for 2GB. Ben started working in radio when he was just 15, and he’s built an incredibly successful career over the past 30 years, with no signs of that stopping. In 1997, Ben became the youngest reporter in history to win a Walkley-Award double in the same year, for his coverage of the Thredbo landslide disaster and excellence in journalism. Ben’s also known for his work on TV, including for Sky News, the Today Show, A Current Affair and Nine News. When he’s not working, Ben is a huge family man, married to his beautiful wife Jodie and proud father of their 3 kids, Freddy, Pearl and Goldie. In this episode Ben tells us so many great stories from his career and family life. We hear how Ben started in the industry as a work experience kid, and always found great mentors to help him in his career. This is one of the reasons why Ben loves doing the same for young people entering the industry - he talks about some of the amazing people who’ve started as work experience kids for him, including Nicola’s daughter, Gabriella, and the way he continues to mentor them and loves seeing them succeed. We find out about the time when Ben was the most nervous interviewing someone, and the bombshell that he dropped in that interview, not knowing how his guest was going to react. He also shares the behind-the-scenes details of one of the most difficult stories he’s ever had to cover. Ben opens up about his family life, the incredibly close relationships he has with his mum and siblings, and the fact that not once, but twice, his family members shared a back fence. And you’ll need to stay tuned to hear the advice Ben gave to his son Freddy about dealing with a school bully - it’s gold! We also hear all about Ben’s relationship with the late John Laws, some of the funny lunches they shared in recent years as well as Lawsie’s last words to Ben. As Nicola says in this episode, Ben is one of the greatest storytellers around, and this chat was so much fun - Ben kept us entertained and enthralled the entire time! We hope you love it as much as we did. This episode is proudly supported by Montgomery Investment Management, trusted experts helping you build and protect your financial future. For further information, please contact David Buckland, Chief Executive Officer or Rhodri Taylor, Account Manager on (02) 8046 5000 or investor@montinvest.com Follow Ben on IG here - https://www.instagram.com/benfordham9/ Listen to the Ben Fordham Live podcast here - https://podcasts.apple.com/au/podcast/ben-fordham-live-on-2gb-breakfast/id157670116 Follow Nicola and Di on IG here - https://www.instagram.com/overthebackfencepodcast/ Watch Over The Back Fence on YouTube here - https://www.youtube.com/@Overthebackfencepodcast/podcastsSee omnystudio.com/listener for privacy information.

Earn 0.25 CPD here: https://quiz.ensombl.com/ENSO-25111321-23030001 0.25 General In this episode, Neil is joined by Alex Zaika, Chief Executive Officer at Global X Australia. They explore the recent surge in demand for gold and gold ETFs in Australia, the fundamentals and investor trends driving this growth, and they compare the performance of gold ETFs to other standout Global X funds. Neil Rogan LinkedIn: https://www.linkedin.com/in/roganneil/ Russell Investments Website: https://russellinvestments.com/ Alex Zaika LinkedIn: https://www.linkedin.com/in/alex-zaika-caia-a1a85612/ Global X Australia Website: https://www.globalxetfs.com.au/ General Disclaimer – https://www.ensombl.com/disclaimer/

Send us a textDave Rosa is President & Chief Executive Officer of NeuroOne ( https://nmtc1.com/ ), a developmental-stage medical technology company developing high-definition, minimally invasive thin film electrodes for the diagnosis and treatment of various neurological conditions ( https://nmtc1.com/technology ). The company's initial focus is on epilepsy and the fast‑growing neurostimulation device market.Mr. Rosa is an entrepreneur with three decades of experience in the medical device industry spanning a variety of technologies and products. In addition to CEO roles with early-stage medical device companies, Mr. Rosa's background also includes senior roles with C.R. Bard Inc., Boston Scientific Inc., and St. Jude Medical, where his responsibilities included marketing, product development and business development. He has been named as an inventor on multiple medical device patents, serves on seven corporate boards, and has raised $200M in the capital markets. Mr. Rosa holds an MBA from Duquesne University and a BS in Commerce and Engineering from Drexel University.IMPORTANT EPISODE LINKS - Electrochemical Testing of a New Polyimide Thin Film Electrode for Stimulation, Recording, and Monitoring of Brain Activity -https://pmc.ncbi.nlm.nih.gov/articles/PMC9611492/First Food and Drug Administration Cleared Thin-Film Electrode for Intracranial Stimulation, Recording, and Monitoring of Brain Activity—Part 1: Biocompatibility Testing -https://pmc.ncbi.nlm.nih.gov/articles/PMC9100917/#NeuroOne #DaveRosa #MinimallyInvasive #ThinFilmElectrodes #Theranostics #Stereoelectroencephalography #NeurologicalConditions #Epilepsy #MovementDisorders #ChronicPain #PsychiatricDisorders #Glioblastoma #CognitiveDisorders #Neurostimulation #NerveAblation #BloodBrainBarrier #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: It's World Diabetes Day and we have a LOT of news to get to! Daily oral insulin tested to prevent T1D, mothers and sons and a T1D link, stem cell updates, Tandem Android news, Omnipod's workplace campaign and more! Find out how to submit your Community Commercial Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. It's world diabetes day! It is marked every year on 14 November, the birthday of Sir Frederick Banting, who co-discovered insulin along with Charles Best in 1922.   WDD was created in 1991 by International Diabetes Federation (IDF) and the World Health Organization and became an official United Nations Day in 2006 with the passage of United Nations Resolution 61/225. There will be a ton of stuff in your feeds today and that's great! I'm going to keep this to a pretty normal in the news episode.. although I do have my own World Diabetes Day announcement – I want YOUR community commercials. You could have an ad for your event or your blog or your project right here! There's a post on the website explaining it all and I'll come back at the end of the episode and tell you more. XX The Primary Oral Insulin Trial (POInT) is the first large-scale clinical trial to test whether giving at-risk children daily oral insulin could prevent or delay type 1 diabetes (T1D). Conducted by researchers from Helmholtz Munich and the Technical University of Munich across five European countries, the study enrolled more than 1,000 children with a genetic risk for T1D. Results published in The Lancet show that while oral insulin did not prevent the development of islet autoantibodies—an early sign of diabetes—it was safe and well tolerated. Importantly, researchers found that some children who received oral insulin developed diabetes more slowly than those given a placebo, suggesting potential protective effects in certain genetic subgroups.   Further analysis revealed that the response to treatment depended on the child's insulin gene variant. Children with genetic versions that raise diabetes risk appeared to benefit, showing delayed onset of the disease, while those without the risk variant did not. These findings point toward a future of personalized prevention, where genetic screening could help identify which children might benefit most from oral insulin. Researchers will continue following the participants until age 12 to assess long-term effects. The study marks a major milestone in decades of diabetes prevention research, highlighting both the promise and complexity of developing tailored, early interventions against type 1 diabetes. XX Joint US-Chinese research looking at generating new beta cells from stomach cells. Upon turning on the "genetic switch," the human stomach cells were converted to insulin-secreting cells within the mice and resembled pancreatic beta cells with respect to gene and protein expression. Encouragingly, when those experiments were done with diabetic mice, insulin secreted from the transformed human cells helped control blood sugar levels and ameliorated diabetes. The scientists hope that a similar approach can be taken to convert cells from a patient's own stomach into insulin-secreting cells directly within the body. Importantly, additional studies are needed to address if this approach is safe and effective to be used in patients. https://www.technologynetworks.com/cell-science/news/human-stomach-cells-tweaked-to-make-insulin-406694 XX A new study in Nature Metabolism may help explain why children born to mothers with type 1 diabetes are less likely to develop the disease early in life compared to those whose fathers or siblings have it. Researchers looked at nearly 2,000 mothers and their children and found that  kids whose moms have type 1 diabetes show changes in their DNA that may actually help protect them. These aren't genetic mutations, but epigenetic changes — chemical tags that turn certain genes on or off. The study found these changes in genes tied to the immune system and type 1 diabetes risk, suggesting that a mother's condition during pregnancy can shape her child's immune response in a protective way. Scientists identified more than 500 areas of DNA where these changes occurred, many in regions that control how the body's immune system works. Most of the changes appeared to calm down the kind of overactive immune response that leads to type 1 diabetes. Researchers even created a "methylation score" to help measure this protective effect. They say the next step is to confirm these results in more diverse groups and figure out exactly how these DNA changes help prevent early diabetes. https://www.news-medical.net/news/20251110/Maternal-type-1-diabetes-may-protect-children-from-developing-the-disease.aspx XX A new study from Karolinska Institutet and Stockholm University reveals that sons born to mothers with type 1 diabetes may develop early vascular dysfunction—independently of metabolic health. The finding may help shape future strategies to prevent cardiovascular disease early in life.     Children of women with type 1 diabetes are known to be at increased risk of developing cardiovascular diseases. This new study, published in Cell Reports Medicine, is the first to show that the risk is linked to early dysfunction in blood vessel cells in sons, even before any metabolic issues arise. The team is now investigating the long-term effects of maternal diabetes, with a particular focus on why sons seem to be affected earlier than daughters. https://medicalxpress.com/news/2025-11-sons-mothers-diabetes-early-vascular.html XX A new study presented at Kidney Week 2025 has shown that the drug finn-uh-near-own  a nonsteroidal mineralocorticoid-receptor antagonist, significantly reduced albuminuria—a key marker of kidney damage—in people with type 1 diabetes (T1D) and chronic kidney disease (CKD). This is the first major breakthrough for this population in more than 30 years. Researchers found that patients taking finerenone saw a 25% average reduction in albuminuria compared to placebo, an improvement that suggests a lower long-term risk for dialysis or kidney transplant. The phase 3 FINE-ONE trial involved 242 adults with T1D and CKD, and results showed benefits as early as three months. The drug was generally well tolerated, with side effects similar to those seen in patients with type 2 diabetes, though mild hyperkalemia (high potassium levels) was slightly more common. Experts say the findings could change the way doctors treat kidney complications in type 1 diabetes, an area that hasn't seen new therapies since the early 1990s. Currently, treatment options rely on blood pressure and blood sugar management, along with renin-angiotensin system (RAS) inhibitors. Finerenone, which is already approved for type 2 diabetes-related CKD, targets overactivation of a receptor that drives kidney damage. Based on these results, Bayer plans to seek FDA approval in 2026 for use in people with T1D and CKD. Researchers and clinicians alike are calling the study "groundbreaking," noting that it opens the door to future research on how finerenone might not just slow kidney decline—but possibly prevent it altogether. https://www.medscape.com/viewarticle/finerenone-offers-hope-kidney-disease-type-1-diabetes-2025a1000uzi?form=login   XX This week, Tandem Diabetes Care (Nasdaq:TNDM) announced a major milestone for its Mobi miniature durable insulin pump system. San Diego-based Tandem revealed that it received FDA approval for the Android version of its Mobi mobile app. Clearance brings Mobi — which the company describes as the world's smallest, durable automated insulin delivery system — to more users. The pump, which pairs with Tandem's Control-IQ+ algorithm, previously worked with iOS software.   Tandem — one of the largest diabetes tech companies in the world — expects to begin a limited rollout next month, followed by full commercial availability in early 2026. This marks the latest milestone for the company, which continues to expand its offerings and widen its reach within the diabetes patient population.   We had a great interview with Tandem on our previous episode, but as I said at the time, it was coming before their earnings call. So here's an update: The company plans to submit the tubeless mobi to the fda before the end of this year.. possible approval and shipping date is hoped for by middle of 2026. Trials for their fully closed loop next-generation algorithm which we tlkaed abou ton the show should be launched in 2026 The Sigi patch pump will be developed and launched as a next-generation version of the Mobi Great job by Dr. David ? Ahn – he posted on IG after getting a message from tandem CEO John Sheridan? 1. First, the Tandem X3 *is* still absolutely in development, contrary to my speculation In yesterday's video. As many of you appropriately pointed out, there is definitely a market for a 300 unit pump, a pump with a screen, and a pump that does not require smartphone control. So from our brief chat, the sense I got that is that the X3 would be more of a refresh of the X2 with newer components, such as a USB-C connector and better memory, rather than a total redesign from the ground up. In terms of timing, all I could get was that it was "not too far distant in the future," which could mean anything I guess, but at least it's still on the way! 2. Next up, he also reassured me that they are working closely with Dexcom to support the G7 15 Day sensor within the next few months. I suspected as much, but it's always good to hear confirmation. 3. Lastly, he did confirm that Tandem is far along in developing a Caregiver/Follow app to allow the remote viewing of glucose and insulin data from a Tandem pump. He explained that it will be based on Sugarmate, the popular diabetes data dashboard app that Tandem acquired back in Jun 2020. While I don't know if every feature will make it into the Tandem caregiver app, Sugarmate is well-liked for its highly customizable dashboard and highly configurable alerts. Sugarmate even has the option to send a text message or phone call for urgent lows. Regardless, a true follow/Caregiver app will be welcomed with open arms by all caregivers and Tandem users who use Libre 3 Plus. https://time.com/7318020/worlds-top-healthtech-companies-2025/ XX Senseonics submits Eversense 365 – their year long implantable CGM for a CE mark, European Approval and expect to launch there soon. Eversense will be integrated with the sequel twist pump – again I'm hearing soon but no timeline. Intersting to note that one year inseration was approved in the US just about a year ago, so the first patients will be having their CGMs changed out – for the first time – pretty soon. https://www.drugdeliverybusiness.com/senseonics-q2-2025-sales-beat-ce-mark/ XX A confusing study out of Rutgers - these researcher say  metformin reduces some of the key benefits normally gained from regular physical activity. These include improvements in blood vessel health, physical fitness, and the body's ability to regulate blood sugar. Since 2006, doctors have typically encouraged patients with elevated blood sugar levels to combine metformin with exercise, expecting that the two proven treatments would produce stronger results together. However, the new research suggests this may not be the case. In this study, Exercise alone improved vascular insulin sensitivity, meaning blood vessels responded better to insulin and allowed more blood flow to muscles. This matters because insulin's ability to open blood vessels helps shuttle glucose out of the bloodstream and into tissues, lowering blood sugar after meals. But when metformin was added, the improvements shrank. The drug also diminished gains in aerobic fitness and reduced the positive effects on inflammation and fasting glucose. The findings don't mean people should stop taking metformin or exercising, Malin said. Instead, it raises urgent questions for doctors about how the two treatments can be combined and the need for close monitoring. Malin hopes future research will uncover strategies that preserve the benefits of both. https://scitechdaily.com/popular-diabetes-drug-metformin-may-cancel-out-exercise-benefits-study-warns/ XX XX https://www.medtechdive.com/news/Revvity-Sanofi-diabetes-test-Kihealth-seed-round/802133/   XX Dexcom recalled an Android app for its G6 glucose sensor due to a software problem that could cause the app to terminate unexpectedly. The issue could cause users to miss alarms, alerts or notifications related to estimated glucose values, according to a Food and Drug Administration database entry posted Oct. 30. The glucose sensor and the app are still available, but Dexcom required users to update the app to a new version. Dexcom began the recall on Aug. 28. The FDA designated the event as a Class 1 recall, the most serious kind. Dexcom sent a notification to customers in September about the software bug, which applies to version 1.15 of the G6 Android app. To use the app, customers must update it to a new version, according to the entry. https://www.medtechdive.com/news/dexcom-recall-g6-cgm-app/804630/ XX https://www.medscape.com/viewarticle/automated-insulin-delivery-boosts-glycemic-control-youth-2025a1000ub3 XX Tidepool partners with smart ring maker OURA.. press release says: to support a groundbreaking dataset intended to be broadly available for diabetes research, with participation limited to individuals who opt in through Tidepool.         Tidepool will pair biometric data from Oura Ring – sleep, activity, heart rate, temperature trends, and menstrual cycles – with diabetes device data, including continuous glucose monitors (CGMs) and insulin pumps. The result will provide researchers with an unprecedented dataset to accelerate the development of new clinical guidelines, next-generation diabetes technology, and personalized care models.   Recruitment is expected to launch in early 2026 through an IRB-approved study. By opting in to this study, participants consent to sharing their data with Tidepool's Big Data Donation Project, where data is de-identified and, with participant consent, shared with academics, researchers, and industry innovators to accelerate diabetes research. https://aijourn.com/tidepool-collaborates-with-oura-to-advance-inclusive-diabetes-research-through-wearables/ XX Eli Lilly launches two new clinical trials for baricitinib. These phase 3 trials will investigate whether the drug can delay T1D onset or progression and will open for recruitment soon. Baricitinib has the potential to extend the "honeymoon period" of T1D, meaning that it could preserve remaining insulin-producing beta cells earlier in disease progression. More beta cells mean better blood sugar management—and potentially reduced long-term complications. JAK inhibitors, including baricitinib, are already FDA-approved for other autoimmune diseases, such as rheumatoid arthritis, alopecia, and more. JAK signaling pathways are associated with overactive immune responses, so blocking this pathway may turn down the immune response. The phase 2 Breakthrough T1D-funded BANDIT study was key in showing that this drug is safe and effective in T1D. Importantly, baricitinib is a once-daily oral pill—meaning its use is simple and easy.   https://www.breakthrought1d.org/news-and-updates/two-new-trials-baricitinib-to-delay-t1d/ XX   Insulet is taking diabetes awareness into the workplace. Having found 79% of people with diabetes have faced bias or misunderstanding at work, the medtech giant is rolling out a range of resources intended to trigger changes in how workplaces approach the condition. Lots going on for Diabetes Awareness month.. some notables.. Insulet's "The Day Diabetes Showed up to Work" campaign. based on a survey of almost 10,000 people 79% of people with diabetes have faced bias or misunderstanding at work,.   Almost 90% of people with diabetes surveyed reported experiencing barriers at work due to their condition, and more than 40% of people with diabetes and caregivers said they have workplace-related anxiety tied to the metabolic disease. Around one-quarter of respondents reported fears that diabetes could limit opportunities or lead to workplace discrimination and judgment, and a similar proportion of people said they conceal their condition. https://www.fiercepharma.com/marketing/widespread-workplace-challenges-people-diabetes-spark-insulet-campaign XX New directive issued by the Trump administration could mean people seeking visas to live in the U.S. might be rejected if they have certain medical conditions, including diabetes or obesity.   The guidance, issued in a cable the State Department sent to embassy and consular officials and examined by KFF Health News, directs visa officers to deem applicants ineligible to enter the U.S. for several new reasons, including age or the likelihood they might rely on public benefits.   The guidance says that such people could become a "public charge" — a potential drain on U.S. resources — because of their health issues or age.   The cable's language appears at odds with the Foreign Affairs Manual, the State Department's own handbook, which says that visa officers cannot reject an application based on "what if" scenarios, Wheeler said.   The guidance directs visa officers to develop "their own thoughts about what could lead to some sort of medical emergency or sort of medical costs in the future," he said. "That's troubling because they're not medically trained, they have no experience in this area, and they shouldn't be making projections based on their own personal knowledge or bias."   Immigrants already undergo a medical exam by a physician who's been approved by a U.S. embassy. https://www.npr.org/2025/11/12/nx-s1-5606348/immigrants-visas-health-conditions-trump-guidance XX SAN DIEGO---Nov. 14, 2025—DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today unveiled 16 new diabetes advocates to represent people living with diabetes globally as part of Dexcom's World Diabetes Day campaign. The advocates – ranging from ages six to 68, spanning various types of diabetes, and hailing from four continents and five countries – were selected from 1,000 open call submissions based on their experiences advocating for people with diabetes in their communities. While each person's experience with diabetes is unique, they share a common passion for advocacy – and use of Dexcom's glucose biosensing technology. "Through advocacy, I strive to show others, especially children and newly diagnosed patients, that diabetes is not a limitation but an opportunity to grow stronger, inspire resilience and pursue ambitious goals," said Maria Alejandra Jove Valerio, one of Dexcom's new advocates. "What began as a diagnosis at age seven has grown into a lifelong mission to uplift others." This effort represents the first time Dexcom has sourced voices from the broader diabetes community specifically for its World Diabetes Day campaign, reinforcing Dexcom's history of and commitment to giving real people with diabetes a platform to share their story on a global stage. Through engaging, editorial-style portraits and deeply personal stories, the campaign highlights each advocate's personal experience with diabetes, what misconceptions about diabetes they'd like to dispel and how they want to inspire others with diabetes to discover what they're made of. To prepare for the spotlight, the group of advocates met in Los Angeles for a World Diabetes Day photoshoot which included a surprise visit from Grammy-nominated artist, actor, producer and Dexcom Warrior Lance Bass and author, producer, actress and Stelo*Ambassador Retta. This visit offered the advocates an opportunity to exchange stories and personal perspectives on the meaning of diabetes advocacy and how they live it each day. Behind the lens at the shoot was another member of the diabetes community—photographer Tommy Lundberg who lives with Type 1 diabetes. "Directing this photoshoot was nothing short of inspiring. Each of these advocates has a unique an XX On what would have been the 100th birthday of its visionary founder Alfred E. Mann, MannKind Corporation (Nasdaq: MNKD), in partnership with Alfred E. Mann Charities and The Diabetes Link, announced the launch of the Centennial Al Mann Scholarship. The new program will distribute $100,000 in scholarship funds to support at least 10 young adult students living with diabetes as they pursue higher education in life sciences.   Launched in Diabetes Awareness Month, the scholarship program honors Alfred E. Mann's enduring legacy of innovation, philanthropy, and his lifelong commitment to improving the quality of human life through medical advancement. Deeply passionate about giving back, Mr. Mann believed that his success should continue to serve humanity long after his passing, a belief that lives on through this initiative.   Each scholarship recipient will be awarded up to $10,000, distributed in annual installments of $2,500 throughout the course of their studies. Depending on the length of their degree program, recipients may receive between two and four installments (up to the full $10,000 per student). The first awards will be made for the 2026 academic year.   "Al Mann dedicated his life to helping people with serious medical conditions live longer, healthier lives. This scholarship is a reflection of that spirit," said Michael Castagna, PharmD, Chief Executive Officer of MannKind Corporation. "By supporting students living with diabetes who are pursuing careers in the life sciences and adjacent fields, we're honoring Al's legacy and investing in the future of innovation and care. This program is about giving back to the community we serve and empowering the next generation to carry forward Al's mission of making a meaningful difference in people's lives."   Alfred E. Mann Charities and MannKind will partner with The Diabetes Link to launch the program to serve young adults (aged 18-22) living with either type 1 or type 2 diabetes with their higher education goals. Those eligible will include incoming freshmen and current students pursuing 2- or 4-year degrees. The application window will open in early 2026, and for those interested in receiving notifications, an early interest form is available. More information about the scholarship will be shared on thediabeteslink.org.   "We're honored to partner with MannKind to expand access to higher education for young adults with diabetes," said Manuel Hernández, Chief Executive Officer of The Diabetes Link. "At a time when the cost of college continues to rise, this scholarship helps ease the financial burden and carries forward the spirit of Al Mann, whose vision and legacy continue to inspire us."   Mr. Mann was MannKind's Chairman of the Board from 2001 until his passing in February 2016 and served as Chief Executive Officer from November 2003 until January 2015. Driven by a desire to improve lives and fill unmet medical needs, for more than six decades he founded 17 companies and developed breakthrough medical devices, including insulin pumps, cochlear implants, cardiac pacemakers and retinal prostheses. In 1997, Mr. Mann saw the potential of a dry powder insulin formulation to change the way diabetes is treated and invested nearly $1 billion to help bring Afrezza® (insulin human) Inhalation Powder to market.   About MannKind MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.   With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.   Learn more at mannkindcorp.com.   About Alfred E. Mann Charities, Inc. Alfred E. Mann Charities, Inc. became active in 2016, following the passing of the organization's benefactor, Alfred E. Mann. Throughout his life, Al was passionate about philanthropy and was dedicated to prolonging and improving the quality of human lives through innovation in the fields of healthcare and the use of medical devices. It was important to Al that his success and assets continue to better human lives even after his own passing.   Alfred E. Mann Charities, Inc. (formerly known as Alfred E. Mann Family Foundation) has similarly placed its primary focus on healthcare and medical innovation, as our organization believes this is where we can have the greatest impact on humanity and human health throughout the world. Alfred E. Mann Charities, Inc. is also dedicated to promoting arts, culture, education, and community development across Los Angeles and throughout the world in order to best serve people and this planet.   Learn more at aemanncharities.org.   About The Diabetes Link The Diabetes Link is the only national nonprofit organization dedicated to empowering young adults living with diabetes. Founded by and for young adults, The Link serves this community through peer support, leadership opportunities, and practical, evidence-based resources designed for real life. Its network of campus and community chapters, active online community, and robust Resource Hub help young adults navigate the transitions of early adulthood while managing diabetes. The organization envisions a future where every young adult living with diabetes has

Story of the Week (DR):Walmart CEO Doug McMillon to retire in January and US operations chief John Furner will take over MMOn February 1, 2026, Mr. McMillon will continue in his capacity as an executive officer of the Company, he will report to the Chairman of the Board of Directors and he will continue to be employed as an associate of the Company through January 31, 2027. Mr. McMillon will also continue his service as a director on the Board until the June 2026 Annual Shareholders' MeetingJohn Furner, 51, a longtime insider and head of Walmart's U.S. operations, will take over. Furner, who started with the company in 1993, has more than 30 years in a variety of leadership roles across all three of Walmart's operating segments, including six years as the head of Walmart's U.S. business.Walmart Announces John Furner as President and Chief Executive Officer and DirectorGreg Penner still chair: Greg is only the third person, after his father-in-law, Rob Walton, and company founder, Sam Walton, to serve in this position.Doug's quotes on stakeholder capitalism:"We simply won't be here if we don't take care of the very things that allow us to exist: our associates, customers, suppliers, and the planet. That's not up for debate.""I think the growing interest in stakeholder capitalism stems from companies genuinely invested in doing good for our world, because it's the right thing to do and because businesses who take this approach are stronger.""Big problems don't rest on the shoulders of government or corporations alone... We need to reinvent capitalism.""Retailers will only survive if their business creates shared value that benefits shareholders and society... Basically, we'll design retail and other businesses so that all stakeholders (as many as possible) benefit: customers, associates/employees, shareholders, the communities we serve, and those in the supply chain."Under McMillon's leadership, Walmart has grown both top-line sales and profits. Its stock price is up 400% over the last decade. McMillon also led significant investments in both technology and labor, which are paying off for the company.Let women (or a black woman) do the work: Compensation Committee, led by chair Carla Harris and Marissa Mayer, are in control of succession planningJapan's Takaichi Says Firms Focusing Too Much on ShareholdersPrime Minister Sanae Takaichi: “I think there has been a trend of too much focus on shareholders. I will revise the corporate governance code to encourage companies to appropriately distribute resources not just to shareholders but to employees.”Takaichi added that she considered the excessive hoarding of capital by firms to be a problem, and said she wanted firms to effectively use it to invest in people including through wage hikes: “I would like to see firms conduct business not just thinking about clients, but also considering their contribution to the broader society.”Disney ditches 'diversity' and 'DEI' in business report for the first time since 2019In the company's 2025 Form 10-K filed after its recent Q4 meeting, the words "diversity," "inclusion," "DEI" or "diversity, equity and inclusion," appeared zero times. While the term "equity" appeared about 130 times, it was only used in a financial context.By contrast, the company's 2024 SEC filing included a dedicated section on diversity, equity and inclusion (DEI)."Our DEI objectives are to build and sustain teams that reflect the life experiences of our audiences, while employing and supporting a diverse array of voices in our creative and production teams," the 2024 report read.Initiatives under that DEI section included programs to engage "creative executives from underrepresented backgrounds" and "over 100 employee-led groups which represent and support the diverse communities that make up our global workforce."Earlier this year, Disney also removed two of its DEI programs, "Reimagine Tomorrow" and "The Disney Look," from its 2024 SEC 10-K report. The "Reimagine Tomorrow" program came under scrutiny after a 2022 meeting the program hosted featured a Disney executive touting her "not-at-all-secret gay agenda."A few other Disney headlines this week:Disney CEO Bob Iger wants people to use AI to make their own content for Disney+Disney is losing millions a day in its fight with YouTube TVDisney's CEO Sequel Isn't Having a Hollywood EndingActivist investor pushes Cracker Barrel shareholders to oust DEI specialistActivist investor Sardar Biglari intensified his campaign against Cracker Barrel's leadership, urging shareholders to vote against CEO Julie Felss Masino and board member Gilbert Dávila in the company's upcoming annual meeting.Two major proxy advisory firms, Institutional Shareholder Services (ISS) and Glass Lewis, also urged shareholders to vote against one or more Cracker Barrel directors over concerns about performance and the company's controversial August rebrand.ISS and Glass Lewis advised shareholders to vote against Dávila, a marketing and diversity specialist who serves as the chair of the compensation committee. Glass Lewis also recommended a vote against Jody Bilney, who chairs the company's nominating and corporate governance committee.Neither proxy firm recommended ousting the CEO.Biglari has launched eight proxy fights in 15 yearsLetter to shareholders: only one stated reason to get rid of Davila: “And why does Mr. Dávila, the board's so-called multicultural marketing expert who signed off on this debacle, deserve re-election?”Goodliest of the Week (MM/DR):DR: Should we really blame billionaires for our own financial struggles? In fact, more Americans say yesPeople increasingly see extreme wealth as contributing to an unfair society, and that sentiment is especially high with Gen Z and millennials.Sixty-seven percent said billionaires are “creating more of an unfair society,” an eight-point increase from the 2024 survey. Should the law limit wealth accumulation? Even Republicans have gone up 12% since last year to just under 50%MM: Netflix CTO says the company has no 'formal performance reviews'Assholiest Which Asshole Do You Blame of the Week (MM):Rivian just doubled its CEO's salary and gave him a $4.6B pay packageChair of the Comp committee Sanford Schwartz, who has 2% influence thanks to CEO Robert Scaringe's dual class dictatorship - the 8K announcing the new pay package blames the Comp committee: “On November 6, 2025, the Compensation Committee of the Board of Directors of Rivian Automotive, Inc. [...] granted an option to purchase up to 36,500,000 shares of the Company's Class A Common Stock to Dr. Robert J. Scaringe.” They also wrote: “The foregoing summary of the terms of the 2025 CEO Award does not purport to be complete”, so we don't really know what the targets are anyway…Schwartz is an exec at Cox Enterprises - who invested $350m in Rivian in 2022“My hope is with the skills that we have,” says Cox president Sandy Schwartz, “and with all the things that we're learning, that we'll be the chief wholesale remarketer for all Rivians someday.”DR: Robert Scaringe, who, in addition to leading his money losing company Rivian, has Altman/Musked not one, but TWO separate spinoff companies (Mind Robotics, where he's on the board and owns 10% of the company, and does robots, and a “micromobility” spinoff called Also, Inc where Scaringe is Also Also on that board)Scaringe did get not one, but THREE degreesHe once estimated he spent “about 5%” of his time with his wife and three kids - they divorced this yearDual class shares, with which Scaringe can vote out the entire board if they DON'T give him whatever comp plan he wants?Elon Musk, who perfected the art of the meme compensation which this basically copies, but maybe worse?22,000,000 shares (60%) in 11 tranches for meeting share price targets between $40 and $140 per share - MEME IT UP BABY!7,250,000 shares in 3 tranches to make income7,250,000 shares in 3 tranches for cash flowMaybe Scaringe plans on a meme campaign to get that price up, get paid, then use the money on his OTHER new spinoff companiesVerizon to Cut About 15,000 JobsOLD NEW CEO Dan Shulman, who was lead independent director and on the board with the old CEO for 7 yearsHe first penned his welcome memo to employees by saying, “The biggest competitive advantage we have is our team.” He followed it with his first earnings call 20 days later with some more inspiration for employees: “To fund our investments in growth, we must significantly cut costs. We will reduce our cost to serve, streamline our operating model and be much more capital efficient.”Everyone loves hearing “you've been fired so we can be more capital efficient”DR: NEW OLD CEO Hans Vestberg, who is still on the board as a “special advisor”His farewell post said, “I've dedicated my life… the last nine years almost… to Verizon. It's an amazing company, amazing employees.”Vestberg once said in an interview he's been keeping a daily score of his emotional state for more than a decade, and when he scores himself below a certain level, he takes no meetings.I wonder if having your ex-lead director as a human body shield for firing 15,000 humans rates as a 7 out of 10?Chair of the Human Resources Committee of the board, Laxman Narasimhan, who has himself experienced being cut from his job as CEO of StarbucksVerizon employees, for costing too muchActivist investor pushes Cracker Barrel shareholders to oust DEI specialistThe CEO Julie Felss Masino, who is the leader and must have chosen to destroy the company by expanding its reach beyond white, overall wearing octogenarians.The DEI specialist - Gilbert Davila - who clearly DEI'ed the logo since his speciality is DEI and he is brown.Sardar Biglari, the “activist” that no one cares about, since he's pushing to vote against CEO Masino (a woman!) and Davila (a brown man!) using the 40% bot-driven outrage machine online as his excuseSardar's letter to investors on November 6 included this reasoning for voting against Davila, who is a diversity marketing expert and has been on the board since 2020: “And why does Mr. Dávila, the board's so-called multicultural marketing expert who signed off on this debacle, deserve re-election?” - that's it, that's his entire reasoning.Sardar's other winning holdings include Steak n' Shake, Maxim magazine, and Jack in the Box, all very popular and not at all pointlessDR: ISS and Glass Lewis, who not only suggested a vote for Masino but AGAINST Davila (because racism?), but GL actually suggested ALSO voting against Jody Bilney (chair of nom and a woman) - WHO WAS PUT THERE BY SARDAR BIGLARI in 2022Headliniest of the WeekDR: No one leaving New York City because of Mamdani, say two top real estate CEOsMM: Why Palantir CEO Alex Karp exhumed the 'whole yard' of his childhood homeRosebud… sorry, Rosita… his childhood dog. And no, that's not a joke - the dog was named Rosita (not Rosebud) and he wanted to rebury it at his New Hampshire homeThe university professors who owned Karp's childhood home "initially balked" at his request. Ultimately, they agreed, he wrote, and "Karp subsequently made a donation to the university where they taught.""Rosita played a tremendous role in our life," the Palantir CEO said. "It was more like, she's very, very high IQ. It was honestly more like a human than a dog." - also, the dog did NOT graduate from an elite universityWho Won the Week?DR: Jason Turner, a Walmart management associate who made $174k last year and is the brother-in-law of new Walmart CEO John Furner.MM: Shoppers at Costco, because Target just rolled this out:Target launches ‘10-4' training, encouraging workers to smile at customersIf employees are 10 feet away from a shopper, they should smile, make eye contact and wave. However, if they are within four feet of the shopper, they should personally greet the guest, smile and initiate a warm and helpful interactionAs if no one shopping there was the fault of employees not smilingAlso, US, because Trump is investigating getting rid of shareholder voting!PredictionsDR: ISS and Glass Lewis announce a “We Give Up 2026” policy where any director who could be blamed for something because they have black or brown skin gets an automatic “vote against” recommendation. MM: Does a window seat on a plane need a window? United Airlines says not. Yes, United Airlines is arguing against a lawsuit brought by people who bought a window seat but there was no window, that a window seat doesn't literally mean has a window. Prediction: Danone claims its Silk Almond Milk remove the “Contains Almonds” warning from the label and puts out a press release that almond milk does not literally mean almonds, it's more like almond-like-milk-colored-drink.

Send us a textRick James is the Chief Executive Officer at SimuTech Group, North America's largest ANSYS Elite Channel Partner. With a 25+ year career at the intersection of mechanical and electrical engineering, he has spearheaded multi-million dollar projects, FEA analyses, drop testing, and reliability-driven design efforts in industries from semiconductors to medical devices.Holding a Doctor of Engineering in Engineering Management and both BSME and MSME degrees from Southern Methodist University, Rick blends deep technical expertise with strategic insight. He began his career at Texas Instruments, tackling IC packaging and structural analysis, progressing through leadership roles at Sulzer, and later heading consulting services at SimuTech.At SimuTech, Rick leads a multidisciplinary team offering simulation and physical testing services across a vast range of disciplines—including structural, thermal, fluids, RF/electromagnetics, optics, VR/AR, and probabilistic design—to “solve the unsolvable.” He is passionate about simulation-driven innovation, the rise of digital twins, and elevating engineering through mentoring and workflow optimization.His thought leadership extends to speaking engagements on fracture mechanics, predictive maintenance, and digital twin methodologies. Rick also serves on Southern Methodist University's Mechanical Engineering Industrial Advisory Board, shaping the future of engineering education.LINKS:Guest LinkedIn: https://www.linkedin.com/in/richardjames/Guest website: https://simutechgroup.com/ Aaron Moncur, hostAbout Being An Engineer The Being An Engineer podcast is a repository for industry knowledge and a tool through which engineers learn about and connect with relevant companies, technologies, people resources, and opportunities. We feature successful mechanical engineers and interview engineers who are passionate about their work and who made a great impact on the engineering community. The Being An Engineer podcast is brought to you by Pipeline Design & Engineering. Pipeline partners with medical & other device engineering teams who need turnkey equipment such as cycle test machines, custom test fixtures, automation equipment, assembly jigs, inspection stations and more. You can find us on the web at www.teampipeline.us

In this episode of Molecule to Market, your host Raman Sehgal discusses the pharmaceutical and biotechnology supply chain with Jean-François Brepson, Chief Executive Officer at PathoQuest. The conversation covers: Navigating 20 years of global leadership roles at Ipsen before moving from the corporate world into an investor-led entrepreneurial adventure The tough decision to refocus PathoQuest from diagnostics into a pure play CRO and pharma services business How a major strategic partnership transformed the company's trajectory and why Jean sees partnerships as a competitive weapon Riding the tailwind of the FDA's move away from animal testing and offering something game-changing in the CMC and GMP space The opportunities ahead for CROs and CDMOs in helping unlock the next wave of innovation Jean-François Brepson is a dedicated leader with deep experience in biotechnology and pharmaceuticals. Since becoming CEO of PathoQuest in 2015, he has built the company into a leading global CRO specializing in quality control of biological drugs using Next Generation Sequencing (NGS). Over his career, he has advanced innovative technologies and solutions that bridge scientific progress with real-world application. Prior to joining PathoQuest, Jean was Senior Vice President at Ipsen, where he led the global GI-Oncology and Endocrinology franchise.   Molecule to Market is sponsored by Bora Pharma, Charles River, and Lead Candidate. Please subscribe, tell your industry colleagues, and help us celebrate the value of the global life science outsourcing space. We'd also appreciate a positive rating!

Nicole Coburn our esteemed guest, and Santa Cruz County's newly appointed Chief Executive Officer, a position that we had no idea existed, when.in fact her list of duties made us wonder how the she even makes it through the day.

In this episode of Inside the Strategy Room, we discuss how the board’s relationship with management is evolving in an era of heightened uncertainty and rapid change. We are joined by board directors Susan Chapman-Hughes and Lan Kang, as well as McKinsey’s Board Services leader Frithjof Lund, and explore how boards are shifting from episodic oversight to continuous engagement, leveraging more frequent dialogue with management teams, investing in trust and culture, and rethinking structure and composition to add strategic value. Susan Chapman‑Hughes is a seasoned board director and former C-Suite executive with deep experience in digital transformation and human-capital strategy. She is currently an independent director at The J.M. Smucker Company and Toast Inc. Lan Kang is a global business leader and board member with extensive experience in healthcare, private equity, and strategy. She currently serves as President and Chief Executive Officer of Azkarra Therapeutics, an early-stage biotechnology company. She serves on the board of Avantor Inc. and has held senior roles across Asia and the U.S. Frithjof Lund is a senior partner and our managing partner in Norway. He leads our Board Services Practice, helping CEOs and boards of directors improve corporate governance and effectiveness. Frithjof also leads our Organization Practice in Scandinavia, helping clients develop high-performing organizations and leaders across the private and public sectors. He is based in our Oslo office. Related insights How public-company boards can thrive by adopting private equity practices How boards can tackle geopolitical risk The Board Perspective – Number 4Support the show: https://www.linkedin.com/showcase/mckinsey-strategy-&-corporate-finance/See www.mckinsey.com/privacy-policy for privacy information

The National Standards Authority of Ireland (NSAI) and the Standards Council of Canada (SCC) have signed a new cooperation agreement, marking the start of closer collaboration between the two countries as national standards bodies. The agreement reflects a shared commitment to strengthen the role of standards in supporting innovation, sustainable growth and trusted trade. Standards provide the common rules that allow technologies to scale, supply chains to function smoothly and businesses to access new markets with confidence. This cooperation builds a bridge between Canada and Ireland's standards systems, ensuring that both countries can share expertise, align on priorities and increase their influence internationally. The new partnership between Canada's national standards body and Ireland's national standards body also opens the door for collaboration in key areas such as digital technologies, sustainability and infrastructure resilience. For businesses, it means greater predictability, fewer duplicative steps and stronger confidence that Canadian and Irish standards will support competitiveness at home and abroad. Geraldine Larkin, Chief Executive Officer, National Standards Authority of Ireland said: "At the heart of the global standardisation system is the principle of working together. This agreement between the NSAI and SCC demonstrates the power of global partnership. By working together, we can better align on emerging priorities, strengthen international cooperation and ensure that standards continue to drive innovation and sustainable growth in both Ireland and Canada." Chantal Guay, Chief Executive Officer, Standards Council of Canada added: "Standards create the trust that underpins innovation and trade. By launching this cooperation with NSAI, we are reinforcing Canada and Ireland's leadership in shaping international standards that support growth, open markets and give businesses the confidence to compete globally." Developed through collaboration and consensus-driven approaches, standards embed resilience into products and services, making them safer, more trustworthy, more sustainable and more adaptable. In addition to developing standards at national and regional level, the SCC and NSAI help ensure that technical experts from both Canada and Ireland contribute to developing ISO and IEC International Standards. See more stories here.

It's one thing to tell a great story.It's another to build and sustain an entire brand universe around it.What began with Elf on the Shelf has evolved into a fully realized Santaverse that spans books, TV, games,music, and more.Now, Christa Pitts and Chanda Bell, co-founders and co-CEOs of The Lumistella Company, are writing the next chapterwith their first YA novel, The Rise of Nicholas the Noble, reengaging fans who grew up with the magic but are aging out.This week, we sat down with Christa and Chanda to talk about worldbuilding, fandom, and how storytelling and brand building can become one and the same.

In this podcast episode, Dr. Jonathan H. Westover talks with Francoise Brougher about rethinking the workforce of the future. Francoise Brougher is a pioneering technology leader with more than 25 years of experience scaling category-defining companies and driving AI-first business transformation. She currently serves as the Chief Executive Officer and Board Member at Pebl (formerly Velocity Global), where she is leading the company's reinvention as an AI-first global workforce platform. Under her leadership, Pebl is reshaping the Employer of Record industry by combining 10+ years of compliance precision with AI-driven simplicity, speed, and transparency, empowering companies to hire and manage talent across 185+ countries. Francoise has a proven track record of building and scaling global organizations responsible for multi-billion-dollar revenue growth. She took both Square (2015) and Pinterest (2019) public as the executive leader of GTM strategy. Earlier at Google, she scaled SMB Global Sales and Operations into a 15B+ business, pioneering the application of machine learning to customer engagement. She currently serves on the boards of Qonto (Chair, Compensation Committee), Too Good To Go, and as a Board Observer at Alan. She started her career in Japan, working for L'Oreal in a manufacturing plant for three years, where she installed a Computer-Assisted Manufacturing System. After her MBA, she joined Booz Allen and Hamilton in Paris and San Francisco. Check out all of the podcasts in the HCI Podcast Network!

In June of 2025, hospice and palliative care pioneer Ira Byock published a white paper outlining the urgent challenges facing the field today. In a nutshell, he expressed concerns that the quality of hospice care in the United States has become highly variable, with disturbing frequency of unethical practices and avaricious owners. He also raised concern that the rapid increase in palliative care program growth during the first two decades of this century has stalled, leaving us with understaffed programs that are often inadequately trained.  Along with Ira, we've invited Kristi Newport, a palliative care doctor and Chief Medical Officer of the American Academy of Hospice and Palliative Medicine, and Brynn Bowman, Chief Executive Officer of the Center to Advance Palliative Care, to discuss these issues and outline a strategic path forward for the field.  In particular we talk about Ira's four-part solution to transform the field and restore its integrity: (1) publishing clear clinical and programmatic standards, (2) making meaningful data publicly available to ensure transparency and accountability, (3) fostering quality-based competition among providers, and (4) embracing the authentic brand of hospice and palliative care—expert care that alleviates suffering and fosters well-being.  So take a listen and dive a little deeper with these resources, and dont forget, you too can get involved in AAHPM (click here for opportunities): Ira's paper titled "A Strategic Path Forward for Hospice and Palliative Care: A White Paper on the Potential Future of the Field" Our previous podcast on "Is Hospice Losing Its Way" Our previous podcast on Private Equity Gobbling Up Hospices plus Hospice and Dementia with Melissa Aldridge, Krista Harrison, & Lauren Hunt CAPC's Serious Ilness Scorecard - a state-by-state look at palliative care capacity CAPC's second annual Palliative Pulse survey offers insight into how palliative care professionals across the country are feeling this year and what they're focused on National Hospice Locator and TCMTalks Podcast by Chris Comeaux and Cordt Kassner  

On this episode, EJ Ledesma, Chief Executive Officer of 360 Orthopedics, joins the podcast to discuss AI advancements and growing the revenue base in specialty practice, the value of partnerships, and his approach to driving growth.

Synopsis: Nimbus Therapeutics CEO Abbas Kazimi walks Alok Tayi through the company's evolving pipeline and playbook for choosing the right risks in a noisy biotech environment. From Werner helicase for MSI-high cancers to a highly selective SIK2 program and GLP-1–adjacent strategies focused on body composition, Abbas details how Nimbus balances rigor, speed, and capital efficiency. He shares candid lessons from pausing and later resurrecting AMPK beta in partnership with Eli Lilly, the decision to remain modality-agnostic but small-molecule-centric, and the importance of knowing when not to chase the latest fad. Throughout, Abbas returns to a consistent theme: success at Nimbus comes from disciplined target selection, deep collaboration, and a culture that empowers teams to make hard calls in service of patients rather than headlines. Biography: Abbas Kazimi is the Chief Executive Officer of Nimbus Therapeutics. Previously, he served as Chief Business Officer, leading the company's strategic and corporate development efforts while overseeing business operations. Since joining Nimbus in 2014, he has helped raise over $630 million in equity financing and led transactions totaling more than $8 billion. Notably, Mr. Kazimi spearheaded the $6 billion sale of Nimbus's TYK2 program to Takeda, the $1.2 billion sale of its NASH (ACC) program to Gilead, and multiple licensing deals exceeding $1.5 billion with partners such as Genentech, Celgene/Roche, and Eli Lilly. Under his leadership, Nimbus has advanced four programs into the clinic, returned over $4 billion to investors, and continues to expand its computational drug discovery and clinical development capabilities. In 2025, Mr. Kazimi joined the board of Unnatural Products (UNP), a biotech company pioneering orally delivered macrocyclic peptides to tackle previously undruggable targets. He also serves on the Editorial Advisory Board for In Vivo magazine, a leading publication offering strategic insights and analysis of the pharmaceutical, biotechnology, medtech, and consumer health industries. Along with his family, he established the Kazimi Family Endowment for Data Science in Oncology at MD Anderson Cancer Center. This endowment reflects their personal commitment to philanthropy and their vision for revolutionizing cancer treatment through data-driven innovation. At the core of Mr. Kazimi's leadership is a deep sense of purpose—one that seeks to change the trajectory of medical diagnoses where options are limited. The ability to give patients, prescribers, and families a new outlook on life is a powerful responsibility—and one he knows the biopharmaceutical sector has the ability to fulfill. Before Nimbus, he was at Extera Partners, LLC (formerly PureTech Development, LLC), where he provided strategic advisory, supported fundraising, and executed numerous business development transactions. Earlier in his career, he was with JSB-Partners, LP, a specialized investment banking and advisory firm serving biotech and pharmaceutical companies. Mr. Kazimi holds a B.A. from the University of Texas at Austin and an M.S. from Harvard University.

Deanne Stewart is CEO at Aware Super, an Australian superannuation fund with over 200 billion AUD in assets under management and the third largest superannuation fund in the country. She has held this role for close to seven years, and was previously Chief Executive Officer at MetLife in Sydney, and prior to that, held a series of financial services roles.Because Deanne is no stranger to podcasting (you can see a range of her other appearances below) we wanted to pick up where some of the other podcasts had picked up and we start by asking what it was about her varied roles - what she calls a "grab bag of experiences - in asset management, life insurance and management consulting that shaped her leadership style and approach at the helm of Aware Super. We reflect on what she seeks to channel as a leader, and Deanne highlights the importance of curiosity about her team, ideas, approaches, and about listening and plugging in to "learning mode".Moving to discuss the priorities now at Aware Super, we discuss their strong ethos around essential workers, and how this translates into a twin focus on achieving the required return but also channeling the responsible ownership ethos that is important to their mission. We discuss recent acquisitions and the consolidation going on within the Australian superannuation fund environment and the need to find global investment opportunities as the funds under management grow.You can find more podcasts featuring Deanne here:Leadership Series with Helen McCabe https://podcasts.apple.com/us/podcast/deanne-stewart-on-the-pivotal-moment-that-shaped-her-career/id1469503665?i=1000703776587Top CEO Series, The Mentor with Mark Bouris https://open.spotify.com/episode/0R0hHl3Q6wfdaBb4JI5WNd?si=K5CBUkSiRSGyfE8dMGQ2qABlenheim Partners https://blenheimpartners.com/episode-109-deanne-stewart/Series 5 of 2025 is kindly sponsored by Diamond Hill. Diamond Hill invests on behalf of clients through a shared commitment to its valuation-driven investment principles, long-term perspective, capacity discipline and client alignment. An independent active asset manager with significant employee ownership, Diamond Hill's investment strategies include differentiated US and non-US equity, alternative long-short equity and fixed income

On this episode, EJ Ledesma, Chief Executive Officer of 360 Orthopedics, joins the podcast to discuss AI advancements and growing the revenue base in specialty practice, the value of partnerships, and his approach to driving growth.

On this episode, EJ Ledesma, Chief Executive Officer of 360 Orthopedics, joins the podcast to discuss AI advancements and growing the revenue base in specialty practice, the value of partnerships, and his approach to driving growth.

Andrew Rosen, Chief Executive Officer of the National Ataxia Foundation, has a dual mission of accelerating research for treatments and cures for Ataxia while supporting the patients affected by this rare disease. Ataxia describes both a group of hereditary genetic diseases and symptoms of lack of coordination seen in other conditions.  While genetic tests exist for hereditary Ataxia, a significant challenge in drug development has been the lack of a reliable biomarker. To encourage drug development, NAF has funded translational research and the world's most extensive study for SCAs, Spinocerebellar Ataxias, providing new data on the progression of the disease and for the design of future trials. Andrew explains, "NAF has been around for a long time. We were founded in the late 1950s by a neurologist in western Minnesota who had a disease called Ataxia in his family. And NAF's mission has really been twofold ever since that. Our formal statement is that we are trying to accelerate the development of treatments and a cure while working to improve the lives of those living with Ataxia. And so we really focus on research and support. We do a lot in the research world. We fund grants for researchers who are looking into the various types of Ataxia. You'd be hard pressed to find an Ataxia researcher in the world, I think I can say now at this point that hasn't received a grant from NAF at one time or another in their career. We also do a lot of translational-type research. We fund the largest natural history study in Ataxias."   "So, the term ataxia itself is even complex because it both describes a genetic disease, and I think of that as capital 'A' - Ataxia, but it's also a symptom of many other conditions. So small 'a', if you will. Ataxia just means a lack of coordination. It comes from a Greek word. And so what I mean by both hereditary and other things is if you, for instance, have too much to drink, you would show signs of Ataxia. You might stumble when you walk, and your speech might be slurred. Those are the two classic symptoms of hereditary Ataxia. Right. So that's really the Ataxias that we at NAF focus on. So hereditary, as in passed from parent to child, there are several hundred forms of hereditary Ataxia, and they continue to find more as more specific genetic mutations are discovered year after year now."  #NationalAtaxiaFoundation #Ataxia #PatientAdvocacy #RareDisease #SCA ataxia.org Download the transcript here

Andrew Rosen, Chief Executive Officer of the National Ataxia Foundation, has a dual mission of accelerating research for treatments and cures for Ataxia while supporting the patients affected by this rare disease. Ataxia describes both a group of hereditary genetic diseases and symptoms of lack of coordination seen in other conditions.  While genetic tests exist for hereditary Ataxia, a significant challenge in drug development has been the lack of a reliable biomarker. To encourage drug development, NAF has funded translational research and the world's most extensive study for SCAs, Spinocerebellar Ataxias, providing new data on the progression of the disease and for the design of future trials. Andrew explains, "NAF has been around for a long time. We were founded in the late 1950s by a neurologist in western Minnesota who had a disease called Ataxia in his family. And NAF's mission has really been twofold ever since that. Our formal statement is that we are trying to accelerate the development of treatments and a cure while working to improve the lives of those living with Ataxia. And so we really focus on research and support. We do a lot in the research world. We fund grants for researchers who are looking into the various types of Ataxia. You'd be hard pressed to find an Ataxia researcher in the world, I think I can say now at this point that hasn't received a grant from NAF at one time or another in their career. We also do a lot of translational-type research. We fund the largest natural history study in Ataxias."   "So, the term ataxia itself is even complex because it both describes a genetic disease, and I think of that as capital 'A' - Ataxia, but it's also a symptom of many other conditions. So small 'a', if you will. Ataxia just means a lack of coordination. It comes from a Greek word. And so what I mean by both hereditary and other things is if you, for instance, have too much to drink, you would show signs of Ataxia. You might stumble when you walk, and your speech might be slurred. Those are the two classic symptoms of hereditary Ataxia. Right. So that's really the Ataxias that we at NAF focus on. So hereditary, as in passed from parent to child, there are several hundred forms of hereditary Ataxia, and they continue to find more as more specific genetic mutations are discovered year after year now."  #NationalAtaxiaFoundation #Ataxia #PatientAdvocacy #RareDisease #SCA ataxia.org Listen to the podcast here

In this essential episode of the Gritty Nurse podcast, host Amie Archibald-Varley engages in a critical discussion with Amy Coupal, CEO of the Ontario Caregiver Organization (OCO), about the vital role of caregivers in Ontario. This conversation illuminates the significant challenges faced by these essential, yet often overlooked, members of the healthcare team. Listeners will gain insight into the dynamics of caregiving and the crucial support available through the OCO. Key Takeaways for Listeners: Caregiver Recognition: Understand why caregivers must be recognized as essential members of the healthcare team in Ontario. Tailored Support: Learn about the need for tailored support and resources specifically designed for diverse caregiving communities. Burnout Prevention: Discover the importance of organizations implementing caregiver-friendly policies to prevent caregiver burnout and improve their experience. Political Awareness: The episode stresses the significance of political awareness and advocacy to drive systemic change for caregivers.

A Clare TD claims the three options put forward by HIQA as part of their review into emergency healthcare into the region should be implemented gradually. It follows the request put forward by 14 Midwest Oireachtas members to meet with Health Minister Jennifer Carroll McNeill to discuss the options put forward by HIQA. The health watchdog's Chief Executive Officer, Angela Fitzgerald, this week stated a new model three must be considered by the Government. Bodyke Fine Gael TD, Joe Cooney, says expanding the UHL site is a good first step, but more measures must follow in due course.

Greetings, and welcome back to the podcast. This episode, we are joined by Mr. John Dielwart - Chairman of TransAlta a TSX listed ectricity generation and wholesale marketing company with a market cap of ~$7 billion. Mr. Dielwart was formerly Chief Executive Officer of ARC Resources Ltd., which owns and operates oil and gas properties in Western Canada. He oversaw the growth of ARC Resources from start-up in 1996 to a company with a total capitalization of approximately $10 billion at the time of his retirement. After his retirement from ARC Resources on January 1, 2013, Mr. Dielwart re-joined ARC Financial Corp. as Vice-Chairman and Partner. ARC Financial is Canada's leading energy-focused private equity manager. In 2020, Mr. Dielwart resigned from the board but remained as Partner and member of ARC Financial's Investment and Governance committees, and currently represents ARC Financial on the board of Aspenleaf Energy Limited.Mr. Dielwart has a Bachelor of Science with distinction (civil engineering) from the University of Calgary. He is a member of the Association of Professional Engineers and Geoscientists of Alberta and is a past-Chairman of the Board of Governors of the Canadian Association of Petroleum Producers. In 2015, Mr. Dielwart was inducted into the Calgary Business Hall of Fame and in 2018 he received the Oil and Gas Council's Canadian Lifetime Achievement Award.Among other things we learned about Building ARC Resources, 1st Montney Wells & Canadian Power Markets.Thank you to our sponsors.Without their support this episode would not be possible:Connate Water SolutionsATB Capital MarketsEPACAstro Oilfield Rentals Platinum EndeavorsTreeline Well ServicesSupport the show

Today, on Notable Leaders' Radio, I speak with Tony Crescenzo, CEO of Intelligent Waves & Founder of Peak Neuro, LLC. He highlights his compelling journey from a resilient upbringing and military service to pioneering leadership insights and transformative healing with brain-training technology.   In today's episode, we discuss: Remember the importance of "always do the right thing." Tony's grandfather's timeless advice served as his moral compass, guiding him through every personal and business decision. He discovered that by valuing integrity, you foster trust and build a strong, lasting reputation. See adversity as an opportunity to grow and learn. Tony's time in the military, especially the hurdles he faced as his military career came to a close, reminds us how much reputation truly matters. Welcome setbacks as moments to build character and become someone others truly respect and trust. To ease conflicts, try to understand the root of fear rather than just anger. Through his journey with anger, he learned that anger is really fear turned upside down. Embracing this awareness enabled him to transition from fear/anger to compassion and a deeper understanding of himself and others in times of challenge. Consider responding to anger with empathy—it can be a beautiful way to strengthen both your work and personal relationships. Prioritize your sleep and mental health with effective strategies. For instance, Tony saw wonderful improvements in his sleep, memory, and mood by using brainwave entrainment. Taking some proactive steps to care for yourself—such as getting good rest and keeping your mind clear—can truly make a significant difference in your happiness and productivity. Adopt the idea of "generals eat last" as your leadership guiding principle. As Tony beautifully shared, inspiring leaders always put their teams first, creating a warm environment full of trust and stability. When you focus on serving and supporting others, it gently builds loyalty and can significantly lift your team's performance. Embracing this approach can truly make your leadership journey more rewarding and fulfilling! Be open to new modalities of healing. Tony lived with PTSD for 30 years. He believed his anger and stress from his time in the military were a part of him and his life now. It wasn't until he stumbled across a new assistive technology that he learned that was not the case. It is also inspired the creation of PeakNeuro, an AI-enabled platform that uses acoustic audio-entrainment to help veterans and leaders regulate stress, get better sleep, and improve human performance overall through cognitive resilience. Is anger and or stress driving your life? If yes, check out PeakNeuro. It may be just the help you have been looking for. RESOURCES: Complementary Resources: Enclosed Link to a published article about the science of PeakNeuro: https://info.peakneuro.com/documents/2025JUN24PCSRwithTrainingSummary.pdf  Guest Bio Tony Crescenzo is the President and Chief Executive Officer of Intelligent Waves (IW), a veteran-owned, mission-driven systems integrator delivering advanced technology solutions in cybersecurity, systems engineering, data science, software development, and cognitive human performance to the U.S. government. Simultaneously, he is the Founder of Peak Neuro, LLC, a neuroscience and AI-powered company. Peak Neuro harnesses proprietary neuroacoustic technology through a mobile app to enhance sleep, emotional resilience, and trauma recovery—especially for veterans and first responders suffering from PTSD, TBI, or chronic stress. Website/Social Links LinkedIn Social Media:  https://www.linkedin.com/in/tonycrescenzo/   Intelligent Waves' website: https:/www.IntelligentWaves.com  Peak Neuro, LLC: https://www.PeakNeuro.com  BOOKS UnSEALed: A Navy SEAL's Guide to Mastering Life's Transitions by Mark Greene & Sheilby Rawson https://amzn.to/47qDR5P Belinda's Bio: Belinda is a sought-after Leadership Advisor, Coach, Consultant and Keynote speaker and a leading authority in guiding global executives, professionals and small business owners to become today's highly respected leaders. As the Founder of BelindaPruyne.com, Belinda works with such organizations as IBM, Booz Allen Hamilton, BBDO, The BAM Connection, Hilton, Leidos, Yale School of Medicine, Landis, and the Discovery Channel. Most recently, she redesigned two global internal advertising agencies for Cella, a leader in creative staffing and consulting. She is a founding C-suite and executive management coach for Chief, the fastest-growing executive women's network. Since 2020, Belinda has delivered more than 72 interviews with top-level executives and business leaders who share their inner journey to success; letting you know the truth of what it took to achieve their success in her Notable Leaders Radio podcast. She gained a wealth of expertise in the client services industry as Executive Vice President, Global Director of Creative Management at Grey Advertising, managing 500 people around the globe. With over 20+ years of leadership development experience, she brings industry-wide recognition to the executives and companies she works with. Whether a startup, turnaround, acquisition, or global corporation, executives and companies continue to turn to Pruyne for strategic and impactful solutions in a rapidly shifting economy and marketplace. Website: Belindapruyne.com Email Address: hello@belindapruyne.com LinkedIn: https://www.linkedin.com/in/belindapruyne  Facebook: https://www.facebook.com/NotableLeadersNetwork.BelindaPruyne/  Twitter: https://twitter.com/belindapruyne?lang=en  Instagram: https://www.instagram.com/belindapruyne/ 

Rural Healthcare: A CEO's Take on Advocacy, Tech and More Host: Phil Sobol, Chief Commercial Officer at CereCore Guest: Lynn Falcone, Chief Executive Officer, Cuero Regional Hospital Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Really Interesting Women The podcast Ep. 160  Amanda MacKenzieAmanda MacKenzie is one of Australia's most influential voices in climate change advocacy and policy communication. As the Chief Executive Officer of the Climate Council, she has spent over a decade transforming how Australians understand and engage with climate science, policy, and action.And whilst terms such as ‘policy communication' seem like government speak, the reality is both brilliant and simple. The organisation's success under my Amanda's leadership lies in its ability to translate complex climate science into understandable, accessible, actionable information for policymakers, media, and the general public. It's not a ‘one size fits all'. It doesn't just present dry scientific data and have you try and interpret its significance. It's a communications strategy that connects climate science to everyday concerns about health, economics, and community wellbeing. Amanda MacKenzie's contributions to climate advocacy and public policy have been widely recognized here and overseas.I enjoyed this conversation because she simplified a complex subject...or a subject that has been made complex. Unnecessarily. Head to the link in my bio to listen to the episode. Visit instagram @reallyinterestingwomen for further interviews and posts of interesting women in history. Follow the link to leave a review....and tell your friendshttps://podcasts.apple.com/au/podcast/really-interesting-women/id1526764849

In this episode of The CX Tipping Point Podcast, Martha Dorris sits down with Frank Bisignano, Commissioner of the Social Security Administration (SSA) and newly appointed Chief Executive Officer of the Internal Revenue Service (IRS).Commissioner Bisignano shares his remarkable career journey, from leading major financial institutions to overseeing operations during the 9/11 attacks, and how those experiences shaped his approach to public service. In his new dual roles at SSA and the IRS, he underscores his commitment to modernization, technology, and customer experience, focusing on how to effectively lead two of the largest organizations that touch nearly every American.Throughout the conversation, he discusses his management philosophy, the importance of technology as an enabler, and his dedication to employee growth and development. He also reflects on his recent letter marking the 90th anniversary of the SSA, highlighting the agency's modernization priorities and renewed focus on serving the public.The discussion explores the Digital First agenda at SSA, which aims to enable 200 million Americans to transact digitally, while still ensuring that services remain accessible by phone and through field offices for those who need them.Tune in to hear more about:His perspective on the depth and diversity of SSA's customersHow he measures success in modern government service deliveryKey improvements and successes already underway at SSAIt was an honor to speak with Commissioner Bisignano, stay tuned, he's already requested a follow-up conversation in six months!Thank you for listening to this episode of The CX Tipping Point Podcast! If you enjoyed it, please consider subscribing, rating, and leaving a review on your favorite podcast platform. Your support helps us reach more listeners! Stay Connected: Follow us on social media: LinkedIn: @DorrisConsultingInternational Twitter: @DorrisConsultng Facebook: @DCInternational Resources Mentioned: Citizen Services Newsletter 2024 Service to the Citizen Awards Nomination Form

Asian stocks advanced for a second consecutive day as progress toward ending the record-long US government shutdown lifted sentiment, sparking a cross-asset rally from commodities to cryptocurrencies.President Donald Trump said he "at some point" would reduce the tariff rate on Indian goods, saying the US was getting "pretty close" to a trade deal with New Delhi."Right now they don't love me, but they'll love us again," Trump said. "We're getting a fair deal." Trump later predicted the nations were "pretty close to doing a deal that's good for everybody." The comments were the latest signal of a possible thaw in the trade dispute that has soured the relationship between the US and India. We heard from Kurt Campbell, Chairman and Co-Founder of The Asia Group. He spoke to Bloomberg's Paul Allen at the UBS Australasia Summit.In the states - Wall Street traders piled into riskier corners of the market, with stocks climbing alongside Bitcoin as the US Senate advanced a plan to end the longest-ever government shutdown, which would remove a significant economic headwind. Bonds lost steam. The risk-on bid lifted the S&P 500 by 1.5%. Technology megacaps, which had been hit the hardest in recent sessions, saw their biggest advance since May. We spoke to Chuck Cumello, President & Chief Executive Officer of Essex Financial. See omnystudio.com/listener for privacy information.

After Democrats scored big wins in key 2025 elections, Republicans are assessing what went wrong and what it means for the 2026 midterms. Mike Rogers, former U.S. congressman from Michigan and now the Michigan GOP Senate candidate, joins the Rundown to discuss what the results reveal about voter sentiment, how the GOP plans to refocus, and why he believes Democrats' growing progressive wing could reshape the political landscape. Tomorrow is Veterans Day, a time to honor those who have served in the U.S. military. Unfortunately, more than 30,000 veterans are living on the streets in the country they sacrificed so much to protect. Darryl J. Vincent, President and Chief Executive Officer at U.S.VETS, joins the Rundown to discuss the "Make Camo Your Cause" campaign, U.S.VETS' mission to prevent and end veteran homelessness, and what must be done to help service members transition to civilian life. Plus, commentary from Jason Chaffetz, FOX News contributor and the host of the Jason In The House podcast on FOX News Radio. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Hans Helmerich is the Chairman of the Board of Helmerich & Payne, Inc., a Tulsa-based energy company and the largest provider of land drilling services in the United States. He previously served as the company's Chief Executive Officer for 25 years, leading its growth and innovation in the oil and gas industry. Under his leadership, H&P developed its innovative FlexRig platform which played a major role in advancing land-based drilling technology.A graduate of Dartmouth College and Harvard Business School's Program for Management Development, Helmerich also serves on other boards and is deeply engaged in community service in Tulsa and beyond.On show you will hear his story and his perspective on mentorship, leadership, faith, prioritizing family, and much more. For more on Hans and Helmerich & Payne check out www.hpinc.com Enjoy the show!

After Democrats scored big wins in key 2025 elections, Republicans are assessing what went wrong and what it means for the 2026 midterms. Mike Rogers, former U.S. congressman from Michigan and now the Michigan GOP Senate candidate, joins the Rundown to discuss what the results reveal about voter sentiment, how the GOP plans to refocus, and why he believes Democrats' growing progressive wing could reshape the political landscape. Tomorrow is Veterans Day, a time to honor those who have served in the U.S. military. Unfortunately, more than 30,000 veterans are living on the streets in the country they sacrificed so much to protect. Darryl J. Vincent, President and Chief Executive Officer at U.S.VETS, joins the Rundown to discuss the "Make Camo Your Cause" campaign, U.S.VETS' mission to prevent and end veteran homelessness, and what must be done to help service members transition to civilian life. Plus, commentary from Jason Chaffetz, FOX News contributor and the host of the Jason In The House podcast on FOX News Radio. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Amy Privette Perko is a leading voice in college sports reform and the Chief Executive Officer of the Knight Commission on Intercollegiate Athletics, a role she has held since 2016 after serving as its executive director since 2005. Under her leadership, the Commission has driven transformative changes in NCAA policy, including requiring teams to meet academic benchmarks for postseason eligibility and revising revenue distribution to reward educational outcomes. Perko has championed financial transparency, gender equity, and athlete well-being through initiatives like the C.A.R.E. Model, which aligns athletics revenue with educational priorities. A former standout basketball player at Wake Forest University, where she earned Academic All-America honors and set multiple school records, Perko combines athletic experience with decades of administrative leadership at the NCAA and the University of Kansas. Her contributions have earned her prestigious honors such as the NCAA Silver Anniversary Award, the Dick Enberg Award, and recognition as a “Game Changer” by Sports Business Journal. Beyond policy advocacy, she is a frequent media commentator and keynote speaker, shaping national conversations on governance, athlete compensation, and the future of college sports.

After Democrats scored big wins in key 2025 elections, Republicans are assessing what went wrong and what it means for the 2026 midterms. Mike Rogers, former U.S. congressman from Michigan and now the Michigan GOP Senate candidate, joins the Rundown to discuss what the results reveal about voter sentiment, how the GOP plans to refocus, and why he believes Democrats' growing progressive wing could reshape the political landscape. Tomorrow is Veterans Day, a time to honor those who have served in the U.S. military. Unfortunately, more than 30,000 veterans are living on the streets in the country they sacrificed so much to protect. Darryl J. Vincent, President and Chief Executive Officer at U.S.VETS, joins the Rundown to discuss the "Make Camo Your Cause" campaign, U.S.VETS' mission to prevent and end veteran homelessness, and what must be done to help service members transition to civilian life. Plus, commentary from Jason Chaffetz, FOX News contributor and the host of the Jason In The House podcast on FOX News Radio. Learn more about your ad choices. Visit podcastchoices.com/adchoices

This week Nicola and Di chat with the passionate and inspiring Sarah Rusbatch. Sarah is the best-selling author of Beyond Booze, an award-winning health and wellness coach, and an accredited grey area drinking coach. Through her programs, Sarah helps women in midlife to live with more confidence, energy and purpose. Since quitting booze in 2019, Sarah has coached more than 10,000 women, hosting sober parties and showing that life can be healthier and lots of fun. In this conversation, we chat to Sarah about the moment that made her realise that it was time to go from ‘Party Girl’ Sarah, always with a drink in her hand, to giving up alcohol completely. Sarah shares how even though she was never an alcoholic, it came to a point where she realised alcohol and drinking had become her go-to way to spend her free time and she was noticing the negative effects it was having on her life. Sarah explains what grey area drinking means and talks about why it’s important not to associate drinking alcohol with stress relief. Stay tuned for some great tips for what you can do in those moments when it’s 5pm and you might be craving a drink. We also talk about the specific challenges for women when it comes to alcohol, and what can happen during menopause if you have a habit of drinking regularly. The good news is, Sarah shares all the positive things that she’s experienced since quitting booze in 2019, the way she feels like she’s aging backwards, the hobbies she’s rediscovered and the new sense of energy and vitality she has. This is such a good episode to learn more about alcohol and to bring awareness to your own relationship with drinking. This isn’t about telling anyone to stop drinking, we love a glass of champers, it’s about being more informed so we can make empowered choices that help us to live our best lives. We loved chatting with Sarah and we hope you enjoy this episode as much as we did. This episode is proudly supported by Montgomery Investment Management, trusted experts helping you build and protect your financial future. For further information, please contact David Buckland, Chief Executive Officer or Rhodri Taylor, Account Manager on (02) 8046 5000 or investor@montinvest.com Follow Sarah on IG here - https://www.instagram.com/sarahrusbatch/ Find out more about Sarah’s work here - https://sarahrusbatch.com/ Buy Sarah’s book Beyond Booze here - https://sarahrusbatch.com/beyond-booze Join the Womens Wellbeing Collective Facebook group here - https://www.facebook.com/groups/342319476897067/ Special Offer: Free linen Laguna towel (valued at $149) with code OTBF on all purchases - https://coastnewzealand.com/discount/OTBF Follow Coast New Zealand on IG here - https://www.instagram.com/coastnewzealand/ Follow Nicola and Di on IG here - https://www.instagram.com/overthebackfencepodcast/ Watch Over The Back Fence on YouTube here - https://www.youtube.com/@Overthebackfencepodcast/podcastsSee omnystudio.com/listener for privacy information.

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Jason Anderson, Chief Executive Officer at Ensera.   Your host, Raman Sehgal, speaks with Jason about the pharmaceutical and biotechnology supply chain, covering: Why he chose BASF over law school, and why McKinsey ultimately was not for him Moving from corporate life into a venture-backed polymer technology start-up before a major exit The search for a PE-backed specialty manufacturing role that led him to Ensera (formerly SteriPack) The importance of appreciating local knowledge when entering new markets Similarities and differences between outsourced services in pharma and medical devices How today's changes, pain, and uncertainty in the markets are creating opportunity Jason Anderson is CEO of Ensera (formerly SteriPack), a global contract design and manufacturing organization serving the pharmaceutical and medical device industries. He has led the company through a period of significant growth and change, including the integration of new design and product development capabilities with Ensera's core manufacturing services, and the launch of the new Ensera trading name.   Prior to Ensera, Jason held global business unit leadership roles at DJO/Enovis and at Saint-Gobain, overseeing businesses ranging from finished medical devices to customized, high-value components for biopharma and medical device industries. Earlier in his career, he held leadership roles at pre-revenue polymer technology start-up Novomer, at McKinsey and Company, and at BASF.   Jason has lived and worked in North America, Asia, and Europe. He holds a BS in Chemical Engineering from the University of Oklahoma and an MBA from Harvard Business School.   Molecule to Market is sponsored by Bora Pharma, Charles River, and Lead Candidate. Please subscribe, tell your industry colleagues, and help us celebrate the value of the global life science outsourcing space. We'd also appreciate a positive rating!

Becoming a successful entrepreneur and maintaining success in a startup business has its own unique set of systemic and structural challenges. Many of those challenges start well before the hunt for investors and developers begins. Often, the toughest barriers can be found in simply trying to meet basic needs for themselves, or their families. Access to food, wraparound services, and community health can make a significant difference at the start of any entrepreneurial endeavor. Add to this, access to education, key resources, technology, and quality mentorship can truly make the difference between an idea launched, or shelved. What can we learn about the work being done here in Northeast Ohio that is truly breaking barriers, and building futures in entrepreneurship?rnrnTiffany Cashon is a Senior Director at Case Western Reserve University's think[box] is a seven story makerspace and entrepreneurship ecosystem that is free and open to the public. Opened in 2015, its goal is to bring together resources for venture creation and entrepreneurship under one roof.rnrnKate Fox Nagel is Chief Executive Officer of MetroHealth Community Health Centers. Launched in 2018, the centers support inclusive and equitable community wellbeing in collaboration with other critical community organizations.rnrnTiffany Scruggs is the VP of Community Access and Executive Director of Community Resource Center at the Greater Cleveland Food Bank. Opened in 2022, the Community Resource Center serves as a one-stop shop for a healthy choice food pantry and to connect with over a dozen social service partners all under one roof.rnrnModerated by Renee RichardrnPresident and CEO of Corporate College, Cuyahoga Community College

In this episode, Bill interviews Michael Maslansky, Chief Executive Officer, Maslansky+Partners, a strategic consultancy and linguistics firm that uses language as the foundation for solving business challenges.

In this episode, Bill interviews Martin Whittaker, Chief Executive Officer, JUST Capital, a nonprofit formed to catalyze private sector leadership on major societal challenges.

Tim is a co-founder and Managing Partner at Angeles Equity Partners.  Tim is responsible for overseeing all aspects of the firm's investment activities. Prior to co-founding Angeles Equity Partners in 2014, Tim co-led the Industrials vertical at The Gores Group with Jordan Katz. Tim was responsible for leading due diligence efforts, driving operational transformation and providing portfolio company oversight.  During his tenure at Gores, Tim served as the Chairman and/or Chief Executive Officer of numerous portfolio companies, and was a member of both the Management and Investment Committees.  Prior to Gores, Tim spent two years at Gateway, where he was responsible for the revenue and margin performance of Services, Software, and Enterprise Products in the Professional Business Unit. Prior to Gateway, Tim spent more than five years at Bain & Company, where he led numerous strategy, M&A and operational improvement engagements for corporate and private equity clients.  Before that, Tim served in various sales leadership and transformation positions at AT&T and began his career with IBM. Tim received a B.A. in Finance from Texas A&M University and an M.B.A. with a concentration in Entrepreneurial Finance from The Wharton School of the University of Pennsylvania.

This week I had the pleasure of speaking with Greg Gartland, Chief Executive Officer of 3E. We discuss 3E's business offerings, how it defines its place in the very competitive world of chemical information management, the role artificial intelligence has in this space, and trends Greg sees driving growth in chemicals, product stewardship, and sustainability. ALL MATERIALS IN THIS PODCAST ARE PROVIDED SOLELY FOR INFORMATIONAL  AND ENTERTAINMENT PURPOSES. THE MATERIALS ARE NOT INTENDED TO CONSTITUTE LEGAL ADVICE OR THE PROVISION OF LEGAL SERVICES. ALL LEGAL QUESTIONS SHOULD BE ANSWERED DIRECTLY BY A LICENSED ATTORNEY PRACTICING IN THE APPLICABLE AREA OF LAW. ©2025 Bergeson & Campbell, P.C.  All Rights Reserved

In this episode of the AgCulture Podcast, Evan Harrison, CEO of Kiss the Ground, explores how storytelling and regenerative agriculture intersect to drive consumer awareness and sustainable change. He shares insights on building momentum for soil health, measuring real impact through media engagement, and creating partnerships with leading brands to fund farmer-led innovation. Discover how communication and collaboration are reshaping agriculture's future. Listen now on all major platforms!Meet the guest: Evan Harrison is the Chief Executive Officer of Kiss the Ground, a nonprofit leading the regenerative agriculture movement through education, storytelling, and strategic partnerships. Since joining in 2022, he has amplified awareness of soil health and supported farmers through grants and media engagement.Connect with our guest on Social Media: LinkedInKiss the GroundWhat you will learn: (00:00) Introduction(01:57) Regenerative storytelling(06:44) Consumer awareness(12:12) Farmer inclusion(18:38) Measuring impact(24:09) Brand collaboration(36:10) Closing thoughtsDiscover the world of agriculture with the "Ag Culture Podcast". This podcast will be a gateway for those passionate about agriculture to explore its global perspectives and innovative practices.Join Paul as he shares his experiences in the agricultural industry, his travels and encounters with important figures around the world.Available on YouTube, Spotify and Apple Podcasts.Subscribe at http://www.agculturepodcast.com and keep an eye out for future episodes, bringing insights and stories from the vibrant world of agriculture.

What happens when your institution has too many systems—and none of them talk to each other? In this episode, Dustin chats with Justin Beck, CEO of Gravyty, about how colleges and universities can stop tech creep from derailing the student experience. Drawing from his background at Apple, Blackboard, Salesforce, Instructure, and now Gravyty, Justin shares hard-earned insights on how schools can create a more connected, intuitive digital journey for students, staff, and alumni. From the power of omnichannel engagement to surprising AI-driven fundraising wins, Justin breaks down how to work smarter with the tech you already have—and how to stop chasing perfection at the expense of progress.Guest Name: Justin Beck - CEO at GravytyGuest Social: LinkedInGuest Bio: Justin Beck is the Chief Executive Officer of Gravyty, a leading provider of AI-driven engagement solutions for higher education and nonprofit institutions. With over two decades of experience in SaaS and education technology, Justin has built and led high-performing global teams across sales, customer success, revenue operations, marketing, and product enablement. He is driven by a deep belief in the power of technology to improve outcomes across the student and constituent lifecycle—from recruitment and retention to alumni engagement and fundraising. Prior to Gravyty, he served as Chief Commercial Officer at Xplor Technologies, a global, multi-vertical SaaS and embedded payments company serving over 100,000 customers in more than 30 markets.Justin's earlier leadership roles include SVP of Global Sales at Instructure (makers of Canvas), and senior positions at Salesforce, Kaltura, EverFi, Blackboard, and Apple. Across each organization, he has played a pivotal role in scaling revenue, entering new markets, and driving strategic transformation. A frequent advisor on go-to-market strategy in mission-driven sectors, Justin brings a blend of operational rigor and customer-centric thinking to every role. He lives in Cincinnati, Ohio, with his wife and their three sports-loving teenage children.  - - - -Connect With Our Host:Dustin Ramsdellhttps://www.linkedin.com/in/dustinramsdell/About The Enrollify Podcast Network:The Higher Ed Geek is a part of the Enrollify Podcast Network. If you like this podcast, chances are you'll like other Enrollify shows too!Enrollify is made possible by Element451 — The AI Workforce Platform for Higher Ed. Learn more at element451.com. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Powering Defense and Driving Innovation for a Safer, Smarter Future in MichiganMatthew Warnick serves as Chief Executive Officer of American Rheinmetall, headquartered in Auburn Hills, Michigan. He has been with Rheinmetall for more than twelve years, guiding its U.S. operations since the establishment of American Rheinmetall (formerly American Rheinmetall Vehicles) in 2019. The company supports Rheinmetall's Vehicle Systems Division with sales, engineering, and program management for defense and commercial markets. Matt is also an eight-year veteran of the United States Marine Corps.

This week, Traci welcomed Wendy Sherry, Chief Executive Officer for Global Health Benefits within International Health at Cigna Healthcare, overseeing healthcare delivery to more than 3,700 clients in over 250 countries.With 30 years at Cigna spanning multiple leadership roles, Wendy is a strong advocate for inclusion and the advancement of women in leadership. She also serves as an advisor to Hello Heart and supports healthcare equity angels.Spoiler alert: 50% of millennial women are experiencing perimenopause symptoms right now, and by 2030, three-quarters of the global workforce will be millennials or Gen Z—meaning this isn't a women's issue, it's a business imperative.What We CoverThe inclusive leadership philosophyWhat perimenopause actually does to your body50% of millennial women have perimenopause symptomsWhich states mandate menopause workplace protectionsWhy this is a business imperative, not a nice-to-haveThe hidden cost of perimenopause stigmaHow Cigna connects employees to menopause specialistsThe talent war you're losing without these benefitsWhat to ask your benefits provider tomorrowKey Quote"If all the good ideas come from me, we are in trouble. You need to have a team that in many ways is smarter than you in certain areas, because it's all about perspective." – Wendy SherryConnect with Wendy Sherry: https://www.linkedin.com/in/wendy-sherry/ Website: https://www.cignaglobal.com/employers/na Connect with Traci here: https://linktr.ee/HRTraciDisclaimer: Thoughts, opinions, and statements made on this podcast are not a reflection of the thoughts, opinions, and statements of the Company by whom Traci Chernoff is actively employed.Please note that this episode may contain paid endorsements and advertisements for products or services. Individuals on the show may have a direct or indirect financial interest in products or services referred to in this episode.

“When you understand the why behind illness, that's when healing truly begins.” —Dr. Michelle NiesleyIn this episode of the Real Health Podcast, Dr. Ron Hunninghake is joined by Dr. Michelle Niesley—Chief Executive Officer of Riordan Clinic, clinical research, and naturopathic doctor specializing in integrative oncology—to explore how science, compassion, and curiosity come together in modern medicine.Dr. Niesley shares her path from research to leadership, the Clinic's 50-year legacy of innovation, and the importance of bridging conventional and integrative care. From terrain-based medicine to whole-brain thinking, this conversation highlights the next chapter of healing at Riordan Clinic.